Download PDF
Semin Respir Crit Care Med 2020; 41(04): 509-521
DOI: 10.1055/s-0040-1710594
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Q Fever (Coxiella Burnetii)

Pedro Pablo España
1   Department of Pulmonology, University Hospital of Galdakao-Usansolo, Galdakao, Bilbao, Spain
,
Ane Uranga
1   Department of Pulmonology, University Hospital of Galdakao-Usansolo, Galdakao, Bilbao, Spain
,
Catia Cillóniz
2   Department of Pneumology, Hospital Clinic of Barcelona, Barcelona, Spain
3   August Pi i Sunyer Biomedical Research Institute—IDIBAPS, University of Barcelona, Barcelona, Spain
4   Biomedical Research Networking Centers in Respiratory Diseases (CIBERES), Barcelona, Spain
5   Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
,
Antoni Torres
2   Department of Pneumology, Hospital Clinic of Barcelona, Barcelona, Spain
3   August Pi i Sunyer Biomedical Research Institute—IDIBAPS, University of Barcelona, Barcelona, Spain
4   Biomedical Research Networking Centers in Respiratory Diseases (CIBERES), Barcelona, Spain
5   Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
› Author Affiliations Funding C.C. is in receipt of an ERS Short Term fellowship and Postdoctoral Grant (Strategic Plan for Research and Innovation in health-PERIS 2016–2020).
Further Information

Publication History

Publication Date:
06 July 2020 (online)

    Permissions and Reprints

Abstract

Q fever is a zoonotic infectious disease caused by the Coxiella burnetii bacterium. It is an obligate intracellular pathogen with a high infection capacity that proliferates exclusively in an acidified medium, forming a lysosome-like vacuole. It presents a peculiar phenomenon called “antigenic phase variation,” produced by a modification in the complexity of the membrane lipopolysaccharides. Q fever can be found worldwide and presents variable clinical features and geographical distribution. It mostly affects people in rural areas who are in contact with animals. The most common type of transmission to humans is via the inhalation of aerosols containing the pathogen, especially those formed from placental derivatives. Wild animals, domestic animals, and ticks are the principal reservoirs.

Diagnosis is mainly made by indirect methods such as serology or by direct methods such as microbiological cultures or tests that detect the specific DNA. Typically, there are two clinical presentations: the acute disease, which is more frequent and often asymptomatic, and a persistent focalized infection in 4 to 5% of patients, generally with a poor evolution. Treatment of the acute form in both children and adults consists of administering doxycycline, while persistent focalized infection should be treated with at least two antibiotics, such as doxycycline and hydroxychloroquine. Several measures should be undertaken to minimize exposure among people working with animals or handling birth products. Different vaccines have been developed to prevent infection, though few data are available.

Keywords

Coxiella burnetii - Q fever - epidemiology - pathogenesis - antigenic phase variation - diagnosis - treatment
 

  • References

  • 1 Hirschmann JV. The discovery of Q fever and its cause. Am J Med Sci 2019; 358 (01) 3-10
    CrossrefPubMedGoogle Scholar
  • 2 Raoult D, Marrie T. Q fever. Clin Infect Dis 1995; 20 (03) 489-495 , quiz 496
    CrossrefPubMedGoogle Scholar
  • 3 Stein A, Saunders NA, Taylor AG, Raoult D. Phylogenic homogeneity of Coxiella burnetii strains as determinated by 16S ribosomal RNA sequencing. FEMS Microbiol Lett 1993; 113 (03) 339-344
    CrossrefPubMedGoogle Scholar
  • 4 Singh S, Kowalczewska M, Edouard S. , et al. Cell extract-containing medium for culture of intracellular fastidious bacteria. J Clin Microbiol 2013; 51 (08) 2599-2607
    CrossrefPubMedGoogle Scholar
  • 5 Pascual-Velasco F. Fiebre Q. Zamora, Spain: Junta de Castilla y León; 1996
    PubMed
  • 6 McCaul TF, Williams JC. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 1981; 147 (03) 1063-1076
    CrossrefPubMedGoogle Scholar
  • 7 Arricau-Bouvery N, Rodolakis A. Is Q fever an emerging or re-emerging zoonosis?. Vet Res 2005; 36 (03) 327-349
    CrossrefPubMedGoogle Scholar
  • 8 Raoult D, Tissot-Dupont H, Foucault C. , et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79 (02) 109-123
    PubMedGoogle Scholar
  • 9 Mahamat A, Edouard S, Demar M. , et al. Unique clone of Coxiella burnetii causing severe Q fever, French Guiana. Emerg Infect Dis 2013; 19 (07) 1102-1104
    CrossrefPubMedGoogle Scholar
  • 10 Hackstadt T. Steric hindrance of antibody binding to surface proteins of Coxiella burnetii by phase I lipopolysaccharide. Infect Immun 1988; 56 (04) 802-807
    CrossrefPubMedGoogle Scholar
  • 11 Baca OG, Paretsky D. Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev 1983; 47 (02) 127-149
    CrossrefPubMedGoogle Scholar
  • 12 Ghigo E, Capo C, Tung C-H, Raoult D, Gorvel J-P, Mege J-L. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing. J Immunol 2002; 169 (08) 4488-4495
    CrossrefPubMedGoogle Scholar
  • 13 Dellacasagrande J, Capo C, Raoult D, Mege JL. IFN-gamma-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J Immunol 1999; 162 (04) 2259-2265
    PubMedGoogle Scholar
  • 14 Dellacasagrande J, Ghigo E, Raoult D, Capo C, Mege J-L. IFN-gamma-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence. J Immunol 2002; 169 (11) 6309-6315
    CrossrefPubMedGoogle Scholar
  • 15 Mege J-L, Meghari S, Honstettre A, Capo C, Raoult D. The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 2006; 6 (09) 557-569
    CrossrefPubMedGoogle Scholar
  • 16 Ghigo E, Honstettre A, Capo C, Gorvel J-P, Raoult D, Mege J-L. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J Infect Dis 2004; 190 (10) 1767-1772
    CrossrefPubMedGoogle Scholar
  • 17 Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 2007; 44 (02) 232-237
    CrossrefPubMedGoogle Scholar
  • 18 Peacock MG, Philip RN, Williams JC, Faulkner RS. Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun 1983; 41 (03) 1089-1098
    CrossrefPubMedGoogle Scholar
  • 19 Arricau-Bouvery N, Souriau A, Bodier C, Dufour P, Rousset E, Rodolakis A. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats. Vaccine 2005; 23 (35) 4392-4402
    CrossrefPubMedGoogle Scholar
  • 20 Eldin C, Mélenotte C, Mediannikov O. , et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev 2017; 30 (01) 115-190
    CrossrefPubMedGoogle Scholar
  • 21 Hackert VH, van der Hoek W, Dukers-Muijrers N. , et al. Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis 2012; 55 (12) 1591-1599
    CrossrefPubMedGoogle Scholar
  • 22 Dupuis G, Vouilloz M, Péter O, Mottiez MC. Incidence of Q fever in Valais [in French]. Rev Med Suisse Romande 1985; 105 (10) 949-954
    PubMedGoogle Scholar
  • 23 Leone M, Honstettre A, Lepidi H. , et al. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol. J Infect Dis 2004; 189 (02) 339-345
    CrossrefPubMedGoogle Scholar
  • 24 Tissot Dupont H, Raoult D, Brouqui P. , et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 1992; 93 (04) 427-434
    CrossrefPubMedGoogle Scholar
  • 25 Dijkstra F, van der Hoek W, Wijers N. , et al. The 2007–2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol 2012; 64 (01) 3-12
    CrossrefPubMedGoogle Scholar
  • 26 Todkill D, Fowler T, Hawker JI. Estimating the incubation period of acute Q fever, a systematic review. Epidemiol Infect 2018; 146 (06) 665-672
    CrossrefPubMedGoogle Scholar
  • 27 Parker NR, Barralet JH, Bell AM. Q fever. Lancet 2006; 367 (9511): 679-688
    CrossrefPubMedGoogle Scholar
  • 28 Signs KA, Stobierski MG, Gandhi TN. Q fever cluster among raw milk drinkers in Michigan, 2011. Clin Infect Dis 2012; 55 (10) 1387-1389
    CrossrefPubMedGoogle Scholar
  • 29 Benson WW, Brock DW, Mather J. Serologic analysis of a penitentiary group using raw milk from a Q fever infected herd. Public Health Rep 1963; 78: 707-710
    CrossrefPubMedGoogle Scholar
  • 30 Kersh GJ, Priestley R, Massung RF. Stability of Coxiella burnetii in stored human blood. Transfusion 2013; 53 (07) 1493-1496
    CrossrefPubMedGoogle Scholar
  • 31 Milazzo A, Hall R, Storm PA, Harris RJ, Winslow W, Marmion BP. Sexually transmitted Q fever. Clin Infect Dis 2001; 33 (03) 399-402
    CrossrefPubMedGoogle Scholar
  • 32 Angelakis E, Raoult D. Q fever. Vet Microbiol 2010; 140 (3–4): 297-309
    CrossrefPubMedGoogle Scholar
  • 33 Anderson A, Bijlmer H, Fournier P-E. , et al. Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013; 62 (RR-03): 1-30
    PubMedGoogle Scholar
  • 34 Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12 (04) 518-553
    CrossrefPubMedGoogle Scholar
  • 35 Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol 1998; 36 (07) 1823-1834
    CrossrefPubMedGoogle Scholar
  • 36 Murphy AM, Field PR. The persistence of complement-fixing antibodies to Q-fever (Coxiella burnetii) after infection. Med J Aust 1970; 1 (23) 1148-1150
    CrossrefPubMedGoogle Scholar
  • 37 Wegdam-Blans MCA, Wielders CCH, Meekelenkamp J. , et al. Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera. Clin Vaccine Immunol 2012; 19 (07) 1110-1115
    CrossrefPubMedGoogle Scholar
  • 38 Musso D, Raoult D. Serological cross-reactions between Coxiella burnetii and Legionella micdadei . Clin Diagn Lab Immunol 1997; 4 (02) 208-212
    CrossrefPubMedGoogle Scholar
  • 39 Boden K, Wolf K, Hermann B, Frangoulidis D. First isolation of Coxiella burnetii from clinical material by cell-free medium (ACCM2). Eur J Clin Microbiol Infect Dis 2015; 34 (05) 1017-1022
    CrossrefPubMedGoogle Scholar
  • 40 Lee M, Jang JJ, Kim YS. , et al. Clinicopathologic features of q fever patients with acute hepatitis. Korean J Pathol 2012; 46 (01) 10-14
    CrossrefPubMedGoogle Scholar
  • 41 Argov O, Weintraub M, Charach G. “Doughnut” granulomas from erythema nodosum in acute Q fever. Isr Med Assoc J 2008; 10 (03) 241-242
    PubMedGoogle Scholar
  • 42 Lepidi H, Houpikian P, Liang Z, Raoult D. Cardiac valves in patients with Q fever endocarditis: microbiological, molecular, and histologic studies. J Infect Dis 2003; 187 (07) 1097-1106
    CrossrefPubMedGoogle Scholar
  • 43 Malou N, Renvoise A, Nappez C, Raoult D. Immuno-PCR for the early serological diagnosis of acute infectious diseases: the Q fever paradigm. Eur J Clin Microbiol Infect Dis 2012; 31 (08) 1951-1960
    CrossrefPubMedGoogle Scholar
  • 44 Million M, Bellevegue L, Labussiere A-S. , et al. Culture-negative prosthetic joint arthritis related to Coxiella burnetii. Am J Med 2014; 127 (08) 786.e7-786.e10
    CrossrefPubMedGoogle Scholar
  • 45 Chieng D, Janssen J, Benson S, Passage J, Lenzo N. 18-FDG PET/ CT scan in the diagnosis and follow-up of chronic Q fever aortic valve endocarditis. Heart Lung Circ 2016; 25 (02) e17-e20
    CrossrefPubMedGoogle Scholar
  • 46 Wang SX, Zhang XC, Wang SY, Shun TT, He YL. (18)F-FDG PET/CT localized valvular infection in chronic Q fever endocarditis. J Nucl Cardiol 2015; 22 (06) 1320-1322
    CrossrefPubMedGoogle Scholar
  • 47 Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis 2002; 2 (11) 686-691
    CrossrefPubMedGoogle Scholar
  • 48 Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005; 5 (04) 219-226
    CrossrefPubMedGoogle Scholar
  • 49 Marrie TJ. Q fever pneumonia. Infect Dis Clin North Am 2010; 24 (01) 27-41
    CrossrefPubMedGoogle Scholar
  • 50 Wielders CCH, Wuister AMH, de Visser VL. , et al. Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands. PLoS One 2014; 9 (03) e91764
    CrossrefPubMedGoogle Scholar
  • 51 Million M, Thuny F, Bardin N. , et al. Antiphospholipid antibody syndrome with valvular vegetations in acute Q fever. Clin Infect Dis 2016; 62 (05) 537-544
    CrossrefPubMedGoogle Scholar
  • 52 Million M, Bardin N, Bessis S. , et al. Thrombosis and antiphospholipid antibody syndrome during acute Q fever: a cross-sectional study. Medicine (Baltimore) 2017; 96 (29) e7578
    PubMedGoogle Scholar
  • 53 Bernit E, Pouget J, Janbon F. , et al. Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 2002; 162 (06) 693-700
    CrossrefPubMedGoogle Scholar
  • 54 Fournier PE, Etienne J, Harle JR, Habib G, Raoult D. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis 2001; 32 (10) 1440-1447
    CrossrefPubMedGoogle Scholar
  • 55 Melenotte C, Million M, Audoly G. , et al. B-cell non-Hodgkin lymphoma linked to Coxiella burnetii . Blood 2016; 127 (01) 113-121
    CrossrefPubMedGoogle Scholar
  • 56 Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect 2012; 65 (02) 102-108
    CrossrefPubMedGoogle Scholar
  • 57 Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001; 33 (03) 312-316
    CrossrefPubMedGoogle Scholar
  • 58 Million M, Walter G, Thuny F, Habib G, Raoult D. Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin Infect Dis 2013; 57 (06) 836-844
    CrossrefPubMedGoogle Scholar
  • 59 Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010; 10 (08) 527-535
    CrossrefPubMedGoogle Scholar
  • 60 Botelho-Nevers E, Fournier P-E, Richet H. , et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis 2007; 26 (09) 635-640
    CrossrefPubMedGoogle Scholar
  • 61 Angelakis E, Edouard S, Lafranchi M-A, Pham T, Lafforgue P, Raoult D. Emergence of Q fever arthritis in France. J Clin Microbiol 2014; 52 (04) 1064-1067
    CrossrefPubMedGoogle Scholar
  • 62 Eldin C, Melenotte C, Million M. , et al. 18F-FDG PET/CT as a central tool in the shift from chronic Q fever to Coxiella burnetii persistent focalized infection: a consecutive case series. Medicine (Baltimore) 2016; 95 (34) e4287
    PubMedGoogle Scholar
  • 63 Marrie TJ, Raoult D. Q fever--a review and issues for the next century. Int J Antimicrob Agents 1997; 8 (03) 145-161
    CrossrefPubMedGoogle Scholar
  • 64 Maltezou HC, Constantopoulou I, Kallergi C. , et al. Q fever in children in Greece. Am J Trop Med Hyg 2004; 70 (05) 540-544
    PubMedGoogle Scholar
  • 65 Terheggen U, Leggat PA. Clinical manifestations of Q fever in adults and children. Travel Med Infect Dis 2007; 5 (03) 159-164
    CrossrefPubMedGoogle Scholar
  • 66 al-Hajjar S, Hussain Qadri SM, al-Sabban E, Jäger C. Coxiella burnetii endocarditis in a child. Pediatr Infect Dis J 1997; 16 (09) 911-913
    CrossrefPubMedGoogle Scholar
  • 67 Sawaishi Y, Takahashi I, Hirayama Y. , et al. Acute cerebellitis caused by Coxiella burnetii. Ann Neurol 1999; 45 (01) 124-127
    CrossrefPubMedGoogle Scholar
  • 68 Boele van Hensbroek M, de Vries E, Dolan G, Schneeberger P. Rash and petechiae as presenting signs of Q fever. Pediatr Infect Dis J 2000; 19 (04) 358
    CrossrefPubMedGoogle Scholar
  • 69 Maltezou HC, Kallergi C, Kavazarakis E, Stabouli S, Kafetzis DA. Hemolytic-uremic syndrome associated with Coxiella burnetii infection. Pediatr Infect Dis J 2001; 20 (08) 811-813
    PubMedGoogle Scholar
  • 70 Ravid S, Shahar E, Genizi J, Schahor Y, Kassis I. Acute Q fever in children presenting with encephalitis. Pediatr Neurol 2008; 38 (01) 44-46
    CrossrefPubMedGoogle Scholar
  • 71 Baquero-Artigao F, del Castillo F, Tellez A. Acute Q fever pericarditis followed by chronic hepatitis in a two-year-old girl. Pediatr Infect Dis J 2002; 21 (07) 705-707
    CrossrefPubMedGoogle Scholar
  • 72 Kubota H, Tanabe Y, Komiya T, Hirai K, Takanashi J, Kohno Y. Q fever encephalitis with cytokine profiles in serum and cerebrospinal fluid. Pediatr Infect Dis J 2001; 20 (03) 318-319
    CrossrefPubMedGoogle Scholar
  • 73 McQuiston JH. Coxiella burnetii (Q fever). In: Long SS, Pickering LK, Prober CG. , eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2009: 885-887
    Google Scholar
  • 74 Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007; 45 (05) 548-555
    CrossrefPubMedGoogle Scholar
  • 75 Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 2002; 162 (06) 701-704
    CrossrefPubMedGoogle Scholar
  • 76 Amit S, Shinar S, Halutz O, Atiya-Nasagi Y, Giladi M. Suspected person-to-person transmission of Q fever among hospitalized pregnant women. Clin Infect Dis 2014; 58 (11) e146-e147
    CrossrefPubMedGoogle Scholar
  • 77 Million M, Roblot F, Carles D. , et al. Reevaluation of the risk of fetal death and malformation after Q Fever. Clin Infect Dis 2014; 59 (02) 256-260
    CrossrefPubMedGoogle Scholar
  • 78 Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun 2003; 4 (01) 82-85
    CrossrefPubMedGoogle Scholar
  • 79 Ayres JG, Flint N, Smith EG. , et al. Post-infection fatigue syndrome following Q fever. QJM 1998; 91 (02) 105-123
    CrossrefPubMedGoogle Scholar
  • 80 Keijmel SP, Delsing CE, Bleijenberg G. , et al. Effectiveness of Long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure study): a randomized controlled trial. Clin Infect Dis 2017; 64 (08) 998-1005
    CrossrefPubMedGoogle Scholar
  • 81 Raijmakers RPH, Keijmel SP, Breukers EMC. , et al. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: one-year follow-up of the Qure study. J Psychosom Res 2019; 116: 62-67
    CrossrefPubMedGoogle Scholar
  • 82 Eldin C, Mailhe M, Lions C. , et al. Treatment and prophylactic strategy for Coxiella burnetii infection of aneurysms and vascular grafts: a retrospective cohort study. Medicine (Baltimore) 2016; 95 (12) e2810
    PubMedGoogle Scholar
  • 83 Meriglier E, Sunder A, Elsendoorn A. , et al. Osteoarticular manifestations of Q fever: a case series and literature review. Clin Microbiol Infect 2018; 24 (08) 912-913
    CrossrefPubMedGoogle Scholar
  • 84 Shapiro RA, Siskind V, Schofield FD, Stallman N, Worswick DA, Marmion BP. A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs. Epidemiol Infect 1990; 104 (02) 267-273
    CrossrefPubMedGoogle Scholar
  • 85 Waag DM, England MJ, Tammariello RF. , et al. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 2002; 20 (19–20): 2623-2634
    CrossrefPubMedGoogle Scholar